Literature DB >> 25360316

The tissue effect of argon-plasma coagulation with prior submucosal injection (Hybrid-APC) versus standard APC: A randomized ex-vivo study.

Hendrik Manner1, Alexander Neugebauer2, Marcus Scharpf3, Kirsten Braun1, Andrea May4, Christian Ell4, Falko Fend3, Markus D Enderle2.   

Abstract

BACKGROUND: Thermal ablation for Barrett's oesophagus has widely been established in gastrointestinal endoscopy during the last decade. The mainly used methods of radiofrequency ablation (RFA) and argon-plasma coagulation (APC) carry a relevant risk of stricture formation of up to 5-15%. Newer ablation techniques that are able to overcome this disadvantage would therefore be desirable. The aim of the present study was to compare the depth of tissue injury of the new method of Hybrid-APC versus standard APC within a randomized study in a porcine oesophagus model.
METHODS: Using a total of eight explanted pig oesophagi, 48 oesophageal areas were ablated either by standard or Hybrid-APC (APC with prior submucosal fluid injection) using power settings of 50 and 70 W. The depth of tissue injury to the oesophageal wall was analysed macroscopically and histopathologically.
RESULTS: Using 50 W, mean coagulation depth was 937 ± 469 µm during standard APC, and 477 ± 271 µm during Hybrid-APC (p = 0.064). Using 70 W, coagulation depth was 1096 ± 320 µm (standard APC) and 468 ± 136 µm (Hybrid-APC; p = 0.003). During all settings, damage to the muscularis mucosae was observed. Using standard APC, damage to the submucosal layer was observed in 4/6 (50 W) and 6/6 cases (70 W). During Hybrid-APC, coagulation of the submucosal layer occurred in 2/6 (50 W) and 1/6 cases (70 W). The proper muscle layer was only damaged during conventional APC (50 W: 1/6; 70 W: 3/6). LIMITATIONS: Ex-vivo animal study with limited number of cases.
CONCLUSIONS: Hybrid-APC reduces coagulation depth by half in comparison with standard APC, with no thermal injury to the proper muscle layer. It may therefore lead to a lower rate of stricture formation during clinical application.

Entities:  

Keywords:  Argon-plasma coagulation; Hybrid-APC; standard APC; submucosal injection

Year:  2014        PMID: 25360316      PMCID: PMC4212496          DOI: 10.1177/2050640614544315

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  18 in total

1.  Submucosal injection of normal saline may prevent tissue damage from argon plasma coagulation: an experimental study using resected porcine esophagus, stomach, and colon.

Authors:  Mitsuhiro Fujishiro; Naohisa Yahagi; Masanori Nakamura; Naomi Kakushima; Shinya Kodashima; Satoshi Ono; Katsuya Kobayashi; Takuhei Hashimoto; Nobutake Yamamichi; Ayako Tateishi; Yasuhito Shimizu; Masashi Oka; Masao Ichinose; Masao Omata
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2006-10       Impact factor: 1.719

Review 2.  Argon plasma coagulation therapy.

Authors:  Hendrik Manner
Journal:  Curr Opin Gastroenterol       Date:  2008-09       Impact factor: 3.287

3.  Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).

Authors:  Hendrik Manner; Thomas Rabenstein; Oliver Pech; Kirsten Braun; Andrea May; Juergen Pohl; Angelika Behrens; Michael Vieth; Christian Ell
Journal:  Endoscopy       Date:  2013-12-18       Impact factor: 10.093

4.  Effectiveness and Safety of PRECISE APC for the treatment of bleeding gastrointestinal angiodysplasia--a retrospective evaluation.

Authors:  A Eickhoff; M D Enderle; D Hartmann; J C Eickhoff; J F Riemann; R Jakobs
Journal:  Z Gastroenterol       Date:  2011-02-04       Impact factor: 2.000

Review 5.  Treatment for Barrett's oesophagus.

Authors:  Jonathan Re Rees; Pierre Lao-Sirieix; Angela Wong; Rebecca C Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Submucosal cushioning with water jet before endoscopic mucosal resection : Which fluids are effective?

Authors:  M G Sold; R Grobholz; S Post; M D Enderle; G F B A Kaehler
Journal:  Surg Endosc       Date:  2008-02       Impact factor: 4.584

7.  Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC.

Authors:  A Eickhoff; R Jakobs; D Schilling; D Hartmann; U Weickert; M D Enderle; J C Eickhoff; J F Riemann
Journal:  Endoscopy       Date:  2007-07       Impact factor: 10.093

8.  Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.

Authors:  O Pech; A Behrens; A May; L Nachbar; L Gossner; T Rabenstein; H Manner; E Guenter; J Huijsmans; M Vieth; M Stolte; C Ell
Journal:  Gut       Date:  2008-05-06       Impact factor: 23.059

9.  Selective tissue elevation by pressure injection (STEP) facilitates endoscopic mucosal resection (EMR).

Authors:  Georg F B A Kähler; Moritz S Sold; Stefan Post; Klaus Fischer; Markus D Enderle
Journal:  Surg Technol Int       Date:  2007

Review 10.  Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.

Authors:  Eric S Orman; Nan Li; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-02       Impact factor: 11.382

View more
  12 in total

1.  Hybrid Argon Plasma Coagulation in Patients With Barrett Esophagus.

Authors:  Oliver Pech
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10

Review 2.  Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times.

Authors:  Nour Hamade; Prateek Sharma
Journal:  Curr Gastroenterol Rep       Date:  2017-08-17

3.  Efficacy and safety of Hybrid-APC for the ablation of Barrett's esophagus.

Authors:  Hendrik Manner; Andrea May; Ioanna Kouti; Oliver Pech; Michael Vieth; Christian Ell
Journal:  Surg Endosc       Date:  2015-06-24       Impact factor: 4.584

4.  Successful endoscopic treatment of stapled J-pouch ileoanal canal anastomotic hemorrhage by argon plasma coagulation: a case report.

Authors:  Takeshi Nishikawa; Keisuke Hata; Shuntaro Yoshida; Koji Murono; Koji Yasuda; Kensuke Otani; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Hiroaki Nozawa; Soichiro Ishihara; Kazuhiko Koike; Toshiaki Watanabe
Journal:  J Med Case Rep       Date:  2016-11-03

5.  Gastric mucosal devitalization (GMD): translation to a novel endoscopic metabolic therapy.

Authors:  Lea Fayad; Andreas Oberbach; Michael Schweitzer; Frederic Askin; Lysandra Voltaggio; Tatianna Larman; Markus Enderle; Hartmut Hahn; Mouen A Khashab; Anthony N Kalloo; Vivek Kumbhari
Journal:  Endosc Int Open       Date:  2019-11-25

6.  Fluid cushion protects against thermal damage during argon plasma coagulation.

Authors:  Roberta Maselli; Paul J Belletrutti; Marco Spadaccini; Piera Alessia Galteri; Thomas Stäbler; Michael Ederer; Alexander Neugebauer; Markus D Enderle; Alessandro Repici
Journal:  Ann Gastroenterol       Date:  2021-09-14

7.  Benefit, tolerance, and safety of hybrid argon plasma coagulation for treatment of Barrett's esophagus: US pilot study.

Authors:  Toshitaka Shimizu; Jason B Samarasena; Kyle J Fortinsky; Rintaro Hashimoto; Nabil El Hage Chehade; Matthew A Chin; Zain Moosvi; Kenneth J Chang
Journal:  Endosc Int Open       Date:  2021-12-14

Review 8.  Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.

Authors:  Massimiliano di Pietro; Marcia I Canto; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

Review 9.  Barrett's Esophagus and Intestinal Metaplasia.

Authors:  Lu Zhang; Binyu Sun; Xi Zhou; QiongQiong Wei; Sicheng Liang; Gang Luo; Tao Li; Muhan Lü
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

10.  Hybrid Argon Plasma Coagulation for Treatment of Gastric Intestinal Metaplasia.

Authors:  Elias Estifan; Yana Cavanagh; Matthew A Grossman
Journal:  Cureus       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.